VivoSense
PrivateLast Round
Series A
Mar 30, 2022
Total Funding Raised
$27.39M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VivoSense operates in Healthcare & Life Sciences and is based in California. Its latest recorded funding round was a Series A round in March 2022.
VivoSense is a healthcare technology company that develops real-world digital clinical measures and provides end-to-end services for wearable sensor physiological monitoring in regulated clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Biotechnology, Health IoT
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VivoSense Comparables
Compare VivoSense with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Koneksa Health | 89% | |
| BioSensics | 81% | |
| Empatica | 80% |
For institutional investors. Book with your work email.
VivoSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 30, 2022 | ||||
| Grant | Oct 20, 2020 | ||||
| Seed | Sep 1, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VivoSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| U.S. Department of Health and Human Services | Grant |
| Perceptive Advisors | Series A |
| United States Department of Defense | Grant |
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 78% MoM.
- Mar 30, 2022
$25M round led by Perceptive Advisors.
For institutional investors. Book with your work email.
VivoSense Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VivoSense's valuation, stock price, and market status.
Is VivoSense a public or private company?
VivoSense is a private company.
What is the current stock price of VivoSense?
VivoSense is a private company, so its shares have no public market price. Caplight tracks VivoSense's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VivoSense worth (valuation)?
Valuation information for VivoSense is not publicly available.
Can I buy VivoSense stock?
VivoSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VivoSense's last funding round?
VivoSense's most recent funding round was Series A on March 30, 2022.
Who are the main investors in VivoSense?
Key investors in VivoSense include Perceptive Advisors.
Will VivoSense IPO soon?
No public IPO plans have been announced for VivoSense.
How can I track VivoSense secondary market activity?
Caplight tracks bids, offers, and trades in VivoSense's shares on secondary markets.